Global Med Technologies(R), Inc.'s Inlog Subsidiary Places Transfusion Management Software in Five Hospitals of the Civil Hospic
November 10 2008 - 9:00AM
PR Newswire (US)
Second Largest French University Hospital System Chooses Software
for Security of Its Computerized Transfusion Solutions DENVER, Nov.
10 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) ,
an international e-Health, medical information technology company,
today announced that its Inlog subsidiary has licensed its
EdgeTrack Transfusion Software (Marketed as "Hemo Serveur" in
France) to 5 HCL Hospitals (Hospices Civils de Lyon) representing
5,500 patient beds. Terms of the agreement were not disclosed.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
EdgeTrack* transfusion management software provides a complete
transfusion record, including patient information, pre and
post-transfusion data tracking, tracing of blood components and
comprehensive tracking of orders, making it easier for HCL's
technicians to provide appropriate blood products for patients.
EdgeTrack's complex features will assist HCL Hospitals in meeting
the diverse needs of their large operation by improving their
processes. It will also enhance workflow by sending and receiving
data with the HCL patient management system, Crystal Net. The first
phase includes installation of a centralized database serving all
five hospitals with care units being progressively added once the
initial five hospitals are live. Automation of the transfusion
services project involves the Cardiology Hospital, Croix- Rousse
Hospital, Edouard Herriot Hospital, Lyon Sud Hospital and Renee
Sabran Hospital. Since EdgeTrack was introduced into the market in
1995 as "Hemo Serveur", it has become a leading hospital
transfusion and traceability information management system in
France with more than 100 licensed hospitals. EdgeTrack easily
connects with most laboratory information systems (LIS) and
hospital information systems (HIS). EdgeTrack interchanges data
with all major blood banking information systems including Inlog's
own EdgeBlood (which is installed in 100% of the French Blood
Establishment's "EFS" Blood Donor Centers). Will Willman, Vice
President of Sales and Marketing EU/ME/Asia at Global Med
Technologies, commented, "We are excited to now have one of the
largest French public hospital systems, Hospices Civils de Lyon, as
a Global Med customer. This large prestigious hospital network,
along with the EFS and 100 other French hospitals customers,
indicates a strong customer preference for Global Med's solutions
in this market. Global Med and Inlog are proving to be a preferred
supplier of IT solutions for blood transfusion management in
Europe." About HCL (Hospices Civils de Lyon) Hospices Civils de
Lyon (HCL) provides efficient healthcare through a coordinated pool
of expertise that spans all clinical specialties. To address the
individual needs of each patient, its 17 member hospitals include
establishments with cross-disciplinary expertise. The organization
counts a total of 5,484 beds. HCL employs more than 22,000
professionals across 5 hospital groups. About Global Med
Technologies, Inc. Global Med Technologies(R), Inc. is an
international medical software company which develops regulated and
non-regulated software products and services for the healthcare
industry. As a leading provider of blood and laboratory software
applications and services, Global Med's products are deployed in 20
countries and serve over 1,600 transfusion centers, blood banks and
laboratories. Global Med's U.S. division, Wyndgate Technologies(R),
provides Vein-to- Vein(R) tracking through its Donor Doc(TM),
SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software
products. Each year, Wyndgate's products and services manage more
than eight million blood components, representing over 27% of the
U.S. blood supply. Global Med's European subsidiary, Inlog, SA, is
a leading provider of donor center and transfusion management
systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. Inlog's products include EdgeBlood*, EdgeTrack*,
EdgeCell, EdgeLab and SAPANET. Global Med's U.S. division,
eDonor(R), provides a web-based donor relationship management
system that integrates recruitment, scheduling, retention and
fulfillment for national as well as local community blood centers
and hospitals. eDonor's products and services are designed to
complement Global Med's strong line of international blood
management and laboratory information software and service
solutions. Global Med's U.S. subsidiary, PeopleMed(R), Inc.,
provides cost-effective customized software validation, consulting
and compliance solutions to hospitals and donor centers. For more
information about Global Med's products and services, please call
800-996-3428 or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/, http://www.inlog.com/,
http://www.edonor.com/, and http://www.wyndgate.com/. *FDA 510(k)
clearance required prior to sales in the U.S. This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Paul Holm, President of
portfolio pr, +1-212-888-4570, , for Global Med Technologies, Inc.
Web site: http://www.globalmedtech.com/
Copyright